GSK CTO, Boehringer Exec On The Metaverse And Pharma’s Foot In The Door

GSK Has Seen ' Lot Of Success' With Bots

Big pharma executives discuss the transformative potential of the metaverse in the life sciences segment and how things are shaping in the virtual world amid the hype. GSK’s senior VP and chief technology officer outlines to Scrip gains made deploying digital twins and bots.

L to R: Ram Deshpande, partner, digital transformation, EY; Agam Upadhyay, senior VP, Chief Technology Officer, GSK USA and Philippe Houben, head, GTM and digital transformation, IMETA , Boehringer Ingelheim

As the metaverse, the next iteration of the internet that encompasses and converges virtual reality (VR) and physical reality in the digital space, promises to change the experience of stakeholders across the healthcare sector, pharma appears keen to be part of what could be the next big thing.

More from Business

More from Scrip